Zhang RW, Shao CP, Huo N, Li MR, Xi HL, Yu M, Xu XY. Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10. World J Gastroenterol 2015; 21(33): 9765-9773 [PMID: 26361424 DOI: 10.3748/wjg.v21.i33.9765]
Corresponding Author of This Article
Xiao-Yuan Xu, Professor, Department of Infectious Diseases, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing 100034, China. xiaoyuanxu6@163.com
Research Domain of This Article
Infectious Diseases
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Zhang RW, Shao CP, Huo N, Li MR, Xi HL, Yu M, Xu XY. Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10. World J Gastroenterol 2015; 21(33): 9765-9773 [PMID: 26361424 DOI: 10.3748/wjg.v21.i33.9765]
World J Gastroenterol. Sep 7, 2015; 21(33): 9765-9773 Published online Sep 7, 2015. doi: 10.3748/wjg.v21.i33.9765
Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10
Ren-Wen Zhang, Cui-Ping Shao, Na Huo, Min-Ran Li, Hong-Li Xi, Min Yu, Xiao-Yuan Xu
Ren-Wen Zhang, Cui-Ping Shao, Na Huo, Min-Ran Li, Hong-Li Xi, Min Yu, Xiao-Yuan Xu, Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China
Author contributions: Xu XY designed the research; Zhang RW, Shao CP, Huo N, Li MR, Xi HL and Yu M performed the research; Zhang RW and Shao CP contributed new reagents/analytic tools; Zhang RW analyzed the data; Zhang RW and Xu XY wrote the paper.
Supported by National Major Project for Infectious Diseases Control, No. 2012ZX10002003-004-003; National Natural Science Foundation of China, No. 81373056; PhD Program Foundation of Ministry of Education of China, No. 20090001110081.
Institutional review board statement: The study was reviewed and approved by Peking University People Hospital Institutional Review Board.
Informed consent statement: All study participants provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Data sharing statement: No additional data are available.
Correspondence to: Xiao-Yuan Xu, Professor, Department of Infectious Diseases, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing 100034, China. xiaoyuanxu6@163.com
Telephone: +86-10-83575787
Received: April 9, 2015 Peer-review started: April 9, 2015 First decision: May 18, 2015 Revised: June 2, 2015 Accepted: July 8, 2015 Article in press: July 8, 2015 Published online: September 7, 2015 Processing time: 151 Days and 5.8 Hours
Core Tip
Core tip: We present novel data on the influence of peginterferon alfa-2a/ribavirin (PegIFNα-2a/RBV) on thyroid function in Chinese genotype 1 hepatitis C virus (HCV)-infected patients over a 48-wk treatment period. The results demonstrate that the prevalence of thyroid dysfunction (TD) was 18.0%. Lower pretreatment serum CXCL10 levels were associated with PegIFNα-2a/RBV induced TD in genotype 1 HCV-infected patients, and female patients exhibited an increased risk for developing TD compared with male patients. Baseline TPOAb positivity may also be a risk factor for TD development. However, most (84%) of the TD cases were reversible. To our knowledge, this is the first study to investigate the association of CXCL10 levels with PegIFNα-2a/RBV induced TD in genotype 1 HCV-infected patients in China.
